Evive Biotechnology Ireland

Evive Biotechnology Ireland Limited, a subsidiary of Yifan Pharmaceutical, is a biopharmaceutical research and development company. The company has developed a product called Ryzneuta, which is currently the only G-CSF treatment drug in the world that has conducted head-to-head clinical studies comparing both with long-acting originator products and short-acting originator products, achieving preset goals, and gaining marketing approval in China, the United States, and Europe. As a non-PEGylated long-acting G-CSF, its main advantages include process innovation, superior efficacy, good safety, earlier dosing to save costs, etc.